How a Potent Anti-neuraminidase Monoclonal Antibody Navigates Recent Immune-evasive Influenza Strains: A Structural Study by Single-particle CryoEM

Affiliations

• ¹ Vir Biotechnology, San Francisco, CA, USA.
• ² Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
• ³ Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK.
• ⁴ School of Biological Sciences and Department of Biochemistry, University of Utah, Salt Lake City, Utah, USA.
• ⁵ Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.